A
TARS icon

AJOVista’s Tarsus Pharmaceuticals TARS Stock Holding History

AJOVista’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$207K Buy
+6,305
New +$177K 0.89% 33

Other funds holding TARS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AJOVista's TARS Position: Q3 2024 in Review

AJOVista opened a new position in Tarsus Pharmaceuticals (TARS) in Q3 2024: 6,305 shares worth $207K. The stake represents 0.89% of the portfolio and ranks #33 among its holdings.

162 funds tracked by Wall St. Rank hold TARS as of Q3 2024.

  • AJOVista held 6,305 shares of Tarsus Pharmaceuticals worth $207K as of Q3 2024.
  • Tarsus Pharmaceuticals was a new AJOVista position in Q3 2024.
  • Tarsus Pharmaceuticals made up 0.89% of AJOVista's portfolio in Q3 2024, its #33 holding.
  • 162 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.